Safety Reference
Warning
H361Suspected of damaging fertility or the unborn child
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Elagolix
pharmaceutical raw material
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
This compound is a pharmaceutical intermediate specifically used in the manufacturing process of Elagolix. It features a complex structure containing multiple aromatic rings and halogen atoms, serving as a key building block in the synthesis of this active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
ethyl 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate
KSJCDYANYVOJPK-MHZLTWQESA-N
CCOC(=O)CCCN[C@@H](CN1C(=O)C(=C(N(C1=O)CC2=C(C=CC=C2F)C(F)(F)F)C)C3=C(C(=CC=C3)OC)F)C4=CC=CC=C4
—